Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (141-150 of 331) with videos related to

Pageof 34
Sort By:
Plos One|May 13, 2016
Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive AnalysisBrian K Chen, Y Tony Yang, Xi Cheng, et al.
Journal of Health Communication|October 6, 2005
A qualitative study of literacy and patient response to HIV medication adherence questionnairesMichael S Wolf, Charles L Bennett, Terry C Davis, et al.
Transfusion|May 14, 2017
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusionsYumi Yoshii, Yoshihiro Fujimura, Charles L Bennett, et al.
Archives of Internal Medicine|April 27, 2011
Enforcement actions involving Medicaid fraud and abuse, 1996-2009Zaina P Qureshi, Ying Liu, Oliver Sartor, et al.
The New England Journal of Medicine|May 23, 2014
Anaphylaxis and hypotension after administration of peginesatideCharles L Bennett, Sony Jacob, Jeffrey Hymes, et al.
American Journal of Hematology|February 12, 2025
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic ReviewJoseph Magagnoli, Kevin Knopf, William J Hrushesky, et al.
Diabetes, Obesity & Metabolism|November 14, 2025
Concerns regarding "GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes"Chien-Hsiang Weng, Charles L Bennett, Joseph Magagnoli, et al.
Expert Opinion on Emerging Drugs|September 17, 2013
Emerging drugs for treatment of anemia of chronic kidney diseaseJametta S Magwood, Akida Lebby, Brian Chen, et al.
British Journal of Sports Medicine|February 19, 2013
Tackling community-acquired methicillin-resistant Staphylococcus aureus in collegiate football players following implementation of an anti-MRSA programmeS Scott Sutton, Jason J Stacy, James Mensch, et al.
Seminars in Thrombosis and Hemostasis|May 26, 2007
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports projectCharles L Bennett, Cara C Tigue, Cara Angelotta, et al.
Pageof 34

Showing results (141-150 of 331) with videos related to

Sort By:
Pageof 34
Plos One|May 13, 2016
Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive AnalysisBrian K Chen, Y Tony Yang, Xi Cheng, et al.
Journal of Health Communication|October 6, 2005
A qualitative study of literacy and patient response to HIV medication adherence questionnairesMichael S Wolf, Charles L Bennett, Terry C Davis, et al.
Transfusion|May 14, 2017
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusionsYumi Yoshii, Yoshihiro Fujimura, Charles L Bennett, et al.
Archives of Internal Medicine|April 27, 2011
Enforcement actions involving Medicaid fraud and abuse, 1996-2009Zaina P Qureshi, Ying Liu, Oliver Sartor, et al.
The New England Journal of Medicine|May 23, 2014
Anaphylaxis and hypotension after administration of peginesatideCharles L Bennett, Sony Jacob, Jeffrey Hymes, et al.
American Journal of Hematology|February 12, 2025
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic ReviewJoseph Magagnoli, Kevin Knopf, William J Hrushesky, et al.
Diabetes, Obesity & Metabolism|November 14, 2025
Concerns regarding "GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes"Chien-Hsiang Weng, Charles L Bennett, Joseph Magagnoli, et al.
Expert Opinion on Emerging Drugs|September 17, 2013
Emerging drugs for treatment of anemia of chronic kidney diseaseJametta S Magwood, Akida Lebby, Brian Chen, et al.
British Journal of Sports Medicine|February 19, 2013
Tackling community-acquired methicillin-resistant Staphylococcus aureus in collegiate football players following implementation of an anti-MRSA programmeS Scott Sutton, Jason J Stacy, James Mensch, et al.
Seminars in Thrombosis and Hemostasis|May 26, 2007
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports projectCharles L Bennett, Cara C Tigue, Cara Angelotta, et al.
Pageof 34